Unique and shared patterns of chemosensory dysfunction distinguish chronic COVID-19 and aspirin-exacerbated respiratory disease

Simple item page
dc.contributor.authorMinichetti Dante G.
dc.contributor.authorDharia Tiffany
dc.contributor.authorBoyd Amelia
dc.contributor.authorBrown Alyson
dc.contributor.authorPerniss Alexander
dc.contributor.authorLemire Evan
dc.contributor.authorHaber Adam L.
dc.contributor.authorRoditi Rachel E.
dc.contributor.authorLee Stella E.
dc.contributor.authorParma Valentina
dc.contributor.authorBuchheit Kathleen M.
dc.contributor.authorLaidlaw Tanya M.
dc.contributor.authorBankova Lora G.
dc.date.accessioned2026-09-09T13:46:08Z
dc.date.issued2026-9
dc.identifier.doi10.1016/j.anai.2026.06.002
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/13663
dc.identifier.uri.pubmedhttps://doi.org/10.1016/j.anai.2026.06.002
dc.sourceAnnals of Allergy, Asthma & Immunology
dc.titleUnique and shared patterns of chemosensory dysfunction distinguish chronic COVID-19 and aspirin-exacerbated respiratory disease

Files

Collections

Published